SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-032514
Filing Date
2023-09-13
Accepted
2023-09-13 17:16:46
Documents
20
Period of Report
2023-09-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 48535
2 ex10-1.htm EX-10.1 5887
3 ex10-1_001.jpg GRAPHIC 362358
4 ex10-1_002.jpg GRAPHIC 392204
5 ex10-1_003.jpg GRAPHIC 411597
6 ex10-1_004.jpg GRAPHIC 438309
7 ex10-1_005.jpg GRAPHIC 393063
8 ex10-1_006.jpg GRAPHIC 294966
9 ex10-1_007.jpg GRAPHIC 51431
  Complete submission text file 0001493152-23-032514.txt   3454962

Data Files

Seq Description Document Type Size
10 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imun-20230913.xsd EX-101.SCH 3045
11 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imun-20230913_lab.xml EX-101.LAB 34240
12 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imun-20230913_pre.xml EX-101.PRE 22379
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3039
Mailing Address 2431 ALOMA AVE #124 WINTER PARK FL 32792
Business Address 2431 ALOMA AVE #124 WINTER PARK FL 32792 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54933 | Film No.: 231253487
SIC: 2834 Pharmaceutical Preparations